Deeks SG - Search Results

1

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. Deeks SG, et al. Blood. 2004 Aug 15;104(4):942-7. doi: 10.1182/blood-2003-09-3333. Epub 2004 Apr 29. Blood. 2004. PMID: 15117761 Free article.

2

HIV-1 protease inhibitors. A review for clinicians.

Deeks SG, Smith M, Holodniy M, Kahn JO. Deeks SG, et al. JAMA. 1997 Jan 8;277(2):145-53. JAMA. 1997. PMID: 8990341 Review.

3

Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.

Deeks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB. Deeks SG, et al. J Infect Dis. 1997 Aug;176(2):514-7. doi: 10.1086/517278. J Infect Dis. 1997. PMID: 9237721

4

The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.

Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J. Deeks SG, et al. J Infect Dis. 1997 Dec;176(6):1517-23. doi: 10.1086/514150. J Infect Dis. 1997. PMID: 9395363 Clinical Trial.

5

Antiretroviral therapy for HIV infection: promises and problems.

Volberding PA, Deeks SG. Volberding PA, et al. Among authors: deeks sg. JAMA. 1998 May 6;279(17):1343-4. doi: 10.1001/jama.279.17.1343. JAMA. 1998. PMID: 9582033 Review. No abstract available.

6

Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.

Deeks SG, Barditch-Crovo P, Lietman PS, Hwang F, Cundy KC, Rooney JF, Hellmann NS, Safrin S, Kahn JO. Deeks SG, et al. Antimicrob Agents Chemother. 1998 Sep;42(9):2380-4. doi: 10.1128/AAC.42.9.2380. Antimicrob Agents Chemother. 1998. PMID: 9736567 Free PMC article. Clinical Trial.

7

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Hellerstein M, et al. Nat Med. 1999 Jan;5(1):83-9. doi: 10.1038/4772. Nat Med. 1999. PMID: 9883844

8

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

9

Factors influencing T-cell turnover in HIV-1-seropositive patients.

McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. McCune JM, et al. J Clin Invest. 2000 Mar;105(5):R1-8. doi: 10.1172/JCI8647. J Clin Invest. 2000. PMID: 10712441 Free PMC article.

10

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

676 results

Search Page